Concepedia

P. Lundin

PL

Statistics

Publications

8

Citations

430

H-Index

8

Active since

1995

Affiliations

AstraZeneca (Sweden)(Current)

Lund University

AstraZeneca (Singapore)

AstraZeneca (United States)

AstraZeneca (United Kingdom)

P. Lundin is an author at AstraZeneca (Sweden) specializing in pharmacokinetics, pharmacology, and pharmacy.

Publications per year

1995–2011

8

Publications

8

Intestinal Permeability Is Associated With Visceral Adiposity in Healthy Women

Anders Gummesson, Lena Carlsson, L. H. Storlien et al. · Obesity · 2011 · 163 citations

, , +17

A pharmacoscintigraphic evaluation of oral budesonide given as controlled‐release (Entocort) capsules

Staffan Edsbäcker, Bengt Bengtsson, Per Larsson et al. · Alimentary Pharmacology & Therapeutics · 2003 · 109 citations · Full text

, , +17

Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn's disease

P. Lundin, Staffan Edsbäcker, Martin Bergstrand et al. · Alimentary Pharmacology & Therapeutics · 2002 · 51 citations

, , +16

Effect of food on the pharmacokinetics of budesonide controlled ileal release capsules in patients with active Crohn’s disease

P. Lundin, Ton Naber, Michael Nilsson et al. · Alimentary Pharmacology & Therapeutics · 2001 · 34 citations · Full text

, , +17

Enhancing Effects of Monohexanoin and Two Other Medium-Chain Glyceride Vehicles on Intestinal Absorption of Desmopressin (dDAVP)

P. Lundin, Malin Bojrup, Helena Ljusberg‐Wahren et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 30 citations

, , +17

1–5 of 8